Specific immune checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) were identified as critical regulatory pathways that inhibit the T-cell response to cancer cells. Here, PDCD1 is linked to cancer.